A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold ResponseDuško Lainšček, Roman Jerala, Mateja Manček‐Keber et al.|Vaccines|2021Cited by 36
Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike proteinDuško Lainšček, Roman Jerala, Tina Fink et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 10
Engineering chimeric PCSK9 for a vaccine against atherosclerosisŠpela Malenšek, Roman Jerala, Duško Lainšček et al.|Molecular Therapy — Methods & Clinical Development|2025Cited by 3